Form 4: Director Gayle Wellborn Executes HQY Stock Option Plan
Statement of Changes in Beneficial Ownership
HealthEquity director Gayle Wellborn exercised options and sold 2,439 shares of common stock under a pre-arranged 10b5-1 plan.
Summary
- Director Gayle Furgurson Wellborn exercised stock options for 2,439 shares at a strike price of $47.21.
- Following the exercise, the director sold the same 2,439 shares at a market price of $90.00 per share.
- The transactions were executed on May 28, 2026, pursuant to a Rule 10b5-1 trading plan adopted on January 14, 2026.
- The director's total beneficial ownership of common stock stands at 19,733 shares post-transaction.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine, pre-planned divestment by a director rather than a signal of company performance.
Positives
- The transaction was conducted under a pre-established Rule 10b5-1 trading plan, which demonstrates disciplined, non-discretionary selling behavior.
Negatives
- The director reduced their direct equity stake in the company by 2,439 shares.
Risks
- None identified; this is a routine insider transaction.
Future Outlook
No forward-looking guidance provided in this filing.
Industry Context
StockSavvy.ai notes that insider selling via 10b5-1 plans is a standard corporate governance practice used by executives and directors to liquidate equity positions while avoiding potential accusations of insider trading based on material non-public information.
Comparison to Industry Standards
- The use of Rule 10b5-1 plans is the industry standard for corporate insiders to manage personal liquidity in publicly traded companies like HealthEquity.
- The transaction volume is relatively small compared to the total outstanding shares of HealthEquity, Inc.
Stakeholder Impact
- Minimal impact on shareholders as the transaction was pre-planned and executed at market rates.
Next Steps
- No future actions or milestones mentioned.
Key Dates
| Date | Description |
|---|---|
| 01/14/2026 | Date the Rule 10b5-1 trading plan was adopted. |
| 05/28/2026 | Date of the option exercise and subsequent share sale. |
| 06/01/2026 | Date the Form 4 was signed and filed. |
Keywords
HealthEquity, HQY, Insider Trading, Form 4, Stock Options, Director Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.